Diminished survival of transfused platelets occurred in two patients given co-trimoxazole, and a third patient taking this drug developed thrombocytopenia. B y means of an indirect immunofluorescence assay antibodies against donor platelets coated with co-trimoxazole were found in the sera in all cases. These antibodies were directed against the trim ethoprim component of cotrimoxazole and not against sulphamethoxazole.
Introduction
Co-trimoxazole (trimethoprim-sulphamethoxazole), a potent antimicrobial drug, is effective in various infections. The antimicrobial activity is due to sequential blockade of the synthesis of folic acid: sulphamethoxazole competes with para-aminobenzoic acid in the synthesis of dihydrofolate, and trimethoprim inhibits dihydrofolate reductase, the enzyme that converts dihydrofolate to tetrahydrofolate.1 Reported haematological effects of co-trimoxazole-:l mostly concern megaloblastic transformation, which probably results from the effect of trimethoprim on dihydrofolate reductase.4 It is not clear, however, whether thrombocytopenia or neutropenia or both in the absence of megaloblastic changes are also due to trimethoprim or caused by the sulphonamide component.'' fi Two patients receiving platelet transfusions showed diminished survival of transfused platelets during treatment with co-trimoxazole, and a third patient taking the drug developed thrombocytopenia and neutropenia. We therefore used an indirect immunofluorescence assay to test sera from these three patients against donor platelets coatcd with trimethoprim, sulphamethoxazole, and the combined agent.
Subjects and methods

PATIENTS AND CONTROLS
Case 1-A 43-year-old man, suffering a blast crisis of chronic myelogenous leukaemia was treated with aggressive chemotherapy (daunorubicin, cytarabine, thioguanine, and cyclophosphamide) and total body irradiation, and given platelet transfusions because of thrombocytopenia. He then began a nine-day course of co-trimoxazole (2 tablets twice daily) for a bacterial infection. From day 3 of this treatment poor survival of transfused platelets was observed. When the course ended survival of transfused platelets became normal. Case 2-A 20-year-old man received a bone marrow transplant for severe aplastic anaemia, and because of deep thrombocytopenia he was given platelet transfusions. T he platelets survived poorly during two periods of six days in which lie received co-trimoxazole (2 tablets twice daily) for a staphylococcal infection. Alter stopping the drut; survival of the donor platelets became normal.
Case 3-A 52-vear-old woman was being treated for staphylococcal spondylodiscitis. Because of penicillin allergy (fever and neutropenia) co-trimoxazole 3 tablets twice daily was instituted. On about the 10th day of treatment neutropenia (20 x 10'; granulocytes/1 (20 m m 1 )) and thrombocytopenia (100 x 109 platelets 1 (100 OOO/mm3)) were found. After withdrawing co-trimoxazole there was a slow recovery.
Controls-Five hospital inpatients with normal platelet counts taking co-trimoxazole for various infections and 10 healthy blood donors served as controls.
METHODS
Platelet survival-Usually preparations from four different donors
containing an average of 150 • HP platelets were transfused. In the absence of immunological destruction this would be expected to increase the circulating platelet count by 20-30 x 109/1 (20 000-30 000/ mnv!) one hour after transfusion (in an adult of about 70 kg). Survival of transfused platelets was regarded as poor when the increase was less than 10 x 10!,/1. I Isolation of platelets-E D T A blood (1 part 5"(, sodium E D T A and 9 parts blood) was centrifuged for live minutes at 150^. The upper layer of plasma containing the platelets was washed three times with phosphate-buffered saline containing 0-3",, sodium E D T A , and a 1 x 109/ml suspension was made in this same medium. Indirect itmnunofliiorescence-Sera from the patients and controls were tested against platelets from healthy donors. Tw o drops of platelet suspension were incubated with two drops of test serum for 00 minutes at room temperature. After washing three times the platelets were incubated with two drops of TRITC-labelled goatantihuman IgG(Fc) (Nordic Pharmaceuticals, Tilburg) for 30 minutes at room temperature. T he platelets were then washed three times and the preparations examined by immunofluorescence microscopy.
Direct immunofluorescence-Platelets from case 2 were tested by direct immunofluorescence. Two drops of platelet suspension were incubated with two drops of TR ITC -labelled goat-antihuman IgG(Fc) for 30 minutes at room temperature.
Incubation of platelets with antimicrobial agent-Platelets were incubated for 15 minutes at room temperature with 0 1 ml cotrimoxazole (16 mg trimethoprim and 80 mg sulphamethoxazole/ml, Wellconie-Nederland BV, Amsterdam), 01 ml trimethoprim (20 mg/ ml, Wellcome-Nederland BV, Amsterdam), and 0 1 ml sulphame thoxazole (80 mg/ml, Hoffmann La Roche, Mijdrecht). After washing, the platelets were incubated wfith the test sera as described for the untreated platelets. T he reactions of platelets incubated with each agent were compared with untreated platelets from the same donor.
Results
In the indirect immunofluorescence tests sera from all three patients were found to contain antibodies against platelets incubated with co-trimoxazole. These antibodies were directed against the trimethoprim component only (table) .
During co-trimoxazole treatment in case 2 the patient's platelets were tested by direct and indirect immunofluorescence with his own serum; both tests were positive regardless of whether the platelets had been incubated with co-trimoxazole. Four wrecks after stopping co-trimoxazolc direct immunofluorescence on the platelets was negative with and without co-trimoxazole incubation. Nevertheless, when the platelets were incubated with co-trimoxazole the indirect immunofluorescence test became positive, indicating that the antibody was still present in his serum.
Indirect immunofluorescence on donor platelets
Donor platelets incubated with:
Healthy donors . .
♦Treated with co-trimoxazole without thrombocytopenia.
Discussion
T w o of our patients show ed decreased survival of transfused platelets d u rin g co-trim oxazole treatm ent. Since co-trim oxazole is advocated for tre a tm e n t7 and prophylaxis in leu k aem ias ,J awareness of this side effect is o f great im portance. A ntibodies against platelets incubated w ith co-trim oxazole w ere detected in sera from these patients and in th e seru m of a patient w ho developed th ro m b o cy to p en ia w hile taking co-trim oxazole. W e think that the th ro m b o cy to p en ia in case 3 and the poor survival of donor platelets in the o th er patients w ere probably caused by these an tib o d ies,1 " since after stopping the d ru g the survival of donor platelets becam e norm al and the th ro m b o cy to p en ia disappeared.
In vitro ex p erim en ts show ed that the antibodies reacted against the trim e th o p rim co m p o n e n t of co-trim oxazole, suggesting that in o u r patients trim eth o p rim was responsible for the effect on platelets and not the su lp h o n am id e com ponent. T h e positive direct im m unofluorescence test in case 2 d u rin g treatm ent w ith co-trim oxazole suggests that the b in d in g of trim ethoprim and antibody to the platelets also occurs in vivo. After treatm e n t was sto p p ed an d trim e th o p rim was no longer present in the circulation, the test becam e negative. T h e indirect im m unofluorescence test, how ever, rem ain ed positive after incubation of the platelets w ith co-trim oxazole, show ing that the antibody was still present and that the patient w ould still be at risk if the d ru g was readm inistered. T h e se observations suggest that platelets coated w ith trim e th o p rim serve as a neoantigen leading to an tib o d y p ro d u ctio n . D ru g -in d u c e d im m u n e th ro m b o cy to p en ia has been show n for several other drugs. T h e best know n exam ples are quinine and q u in id in e," 12 b u t allylisoprolacetylcarbam ide13; sulphafurazole, diazepam , and p h e n y to in 11; and rifam p icin 15 have also been im plicated. W h y som e patients develop these antibodies and others do not rem ains a subject for fu rth e r study. I Ferone, R, Burchall, J J, and Hitchings, G H, Molecular Pharmacology, 1968, 5, 49. Australian Drug Evaluation Committee, Medical Journal of A ustralia, 1972, 1, 435. II Association, 1977, 237, 352. 8 Hughes, W T , Nezv England Journal of Medicine, 1977, 297, 138. ,J Enno, A, el al, Lancet, 1978, 2, 395. 10 Brand, A, et al, Excerpta Medica International Congress Series, 1977, 415, 639. 11 Shulman, N R , Journal of Experimental Medicine, 1958, 107, 711. Karpatkin, S, American Journal of the Medical Sciences, 1971, 262, 69. 1:1 Ackroyd, J F, Clinical Science, 1949 , 7, 249. 11 Cimo, P L , et al, American Journal of Hematology, 1977 i:' Blajchman, M A, et al, British M edical Journal, 1970, 3, 24. (Accepted 7 August 1979)
ONE H U N D R E D YEARS A G O
During the last two months, there have been many cases of scarlet fever among the boys at Eton. As is well known, the boys arc distributed in the town in the various houses of the tutors and dames. W hen a case of scarlet fever or other infectious fever appears in a house, the rule is for the tutor to send a circular to the parents of the boys in that particular house informing them of the fact that there is fever in it, and giving them the option of at once removing the boys or of allowing them to remain. II a second case occur in the same house, a second circular is at once addressed to ihe parents advising them of it. This, as far as it goes, is satisfactory; not so the rule, as we understand it, of the head master, which docs not permit a parent to remove his boy from a house in which there is no fever. It must be borne in mind that the boys from an infected house must needs meet-in the playground, the class-room, or the chapelboys from the other houses, and thus make the convection of contagion not only easy but probable. We have high authority tor the statement that, in some families, scarlet fever is certain death to the individual it may attack. But, even in its ordinary form, there is always the possi bility of some sequela, such as deafness, idiocy, or kidney-disease resulting, and injuring the sufferer for life. Against such a disease, then, no precautions can be deemed too stringent; and we are of opinion that the head master assumes a grave responsibility in refusing a parent the right of removing his child from an appreciable source of danger. During the late epidemic, eight cases of scarlet fever were removed from different houses at Eton and placed in the sanatorium. These have recovered; but one boy, who undoubtedly had scarlet fever, remained in the tutor's house and died from a sequela. This case was in the first instance of a mild nature, and, being regarded as doubtful, was not removed to the sanatorium. For some days after he first suffered from sore-throat and a red flush, he mixed with the other boys. Obviously he should have been sent into the sanatorium, and that none the less because his case was doubtful. It is those very cases in which all the symptoms are not clearly marked which are so dangerous, for the reason that they are allowed to mix with the other boys. No doubt there were other slight cases in the school which were merely regarded as sore-throat, and therefore left at large. T he isolation of doubtful cases is doubly useful; it prevents the further spread of disease, and ensures the patient, who in many eases may only be suffering from a slight attack, against those sequela: to which, for at least three weeks after the inception of the poison, he is as liable as he would be in a more grave attack. T he sanatorium is a detached villa standing in some fields a little way out of the town; it contains eight wards, four on each floor. Each ward contains one bed, a window, and a fireplace. T h e bath was out of order when we visited the sanatorium, and consequently was not being used, although there were seven boys at the time in the sanatorium convalescing from scarlet fever. T he linen at the sanatorium is disinfected by being soaked in a solution of chloride of lime, before being sent into the town of Windsor to be washed. It would be better to burn it, or, at all events, have it well baked. Little is at present known as to the mode of action of disin fectants, and it is by no means certain that a solution of chloride of lime, which will not destroy the linen, will destroy the contagion of scarlet fever. At a school like Eton, where as many as nine hundred boys meet every day, there should be provision for continuous medical inspection, so that any suspicious case might be at once isolated. This is the only means of checking the spread of infection. Such an inspection takes place at many large public schools-among them, we believe, Marlborough, Westminster, and Rugby. (British Medical Journal, 1879.) 
